Cite
HARVARD Citation
Hasanov, M. et al. (2021). An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. Oncoimmunology. p. . [Online].